Istituto Superiore di Sanità, Department of Cell Biology and Neurosciences, Rome, Italy.
Immunobiology. 2010 Sep-Oct;215(9-10):713-23. doi: 10.1016/j.imbio.2010.05.008. Epub 2010 Jun 4.
Toll-like receptor (TLR) 3 recognizes double-stranded RNA and triggers the production of type 1 interferon and inflammatory cytokines/chemokines. Its engagement in dendritic cells (DCs) induces their maturation into potent immunostimulatory cells endowed with the capacity to efficiently cross-prime T lymphocytes. Owing to these properties, TLR3 agonists are currently under investigation as promising adjuvants in DC-based immunotherapy protocols for the treatment of viral and neoplastic diseases. Thus, a detailed understanding of the cascade of events specifically triggered in DCs upon engagement of this receptor is of great interest in translational research. In this review, we summarize the current knowledge on TLR3 signalling in DCs and highlight similarities and differences with respect to other cell types.
Toll 样受体 (TLR) 3 识别双链 RNA,并触发 1 型干扰素和炎症细胞因子/趋化因子的产生。其与树突状细胞 (DC) 的结合诱导它们成熟为具有有效交叉刺激 T 淋巴细胞能力的强效免疫刺激细胞。由于这些特性,TLR3 激动剂目前正在作为基于 DC 的免疫治疗方案的有前途的佐剂进行研究,用于治疗病毒和肿瘤疾病。因此,在翻译研究中,详细了解该受体结合后在 DC 中特异性触发的事件级联反应具有重要意义。在这篇综述中,我们总结了 TLR3 在 DC 中的信号转导的最新知识,并强调了与其他细胞类型的相似性和差异。